Le Lézard
Classified in: Tourism and vacations, Health, Covid-19 virus
Subject: AVO

WTTC calls on the CDC to stop "singling out" the cruise industry with harmful and unnecessary measures


LONDON, Jan. 19, 2022 /PRNewswire/ -- Speaking at the Fitur trade fair in Madrid Spain, Julia Simpson, WTTC President & CEO said:

"While we welcome the expiration of the CDC's conditional sail order, its decision to continue elevated travel health notices is nonsensical.  

"The cruise industry has proven time and again that its enhanced health and safety protocols consistently achieve significantly lower rates of COVID-19 occurrence than onshore.

"WTTC calls upon the CDC to stop singling out the cruise industry with harmful and unnecessary measures. Cruise lines have an excellent record for health and safety, and cruising continues to offer extraordinary travel experiences."

SOURCE World Travel & Tourism Council


These press releases may also interest you

at 17:16
Yesterday, Governor Ned Lamont signed House Bill 5500 (HB 5500) into law which includes provisions to establish a permanent Rare Disease Advisory Council (RDAC) in the state of Connecticut. Connecticut established a temporary rare disease task force...

at 17:11
Abbott to release limited quantities of EleCare® branded specialty formulasProduct will be released immediately free of charge to children in needParents and caregivers in urgent need should contact their healthcare professionals or Abbott at...

at 17:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new study data demonstrating the ability of its TissueCypher® Barrett's Esophagus test to independently predict malignant...

at 17:05
HepQuant, LLC, a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced preliminary data from the SHUNT-V Pivotal study in oral and poster...

at 17:05
Medexus Pharmaceuticals (Medexus) has been informed by medac, a strategic partner of Medexus, that medac received acknowledgement of receipt from the U.S. Food and Drug Administration (FDA) of the New Drug Application resubmission for Treosulfan...

at 17:00
HLS Therapeutics Inc. ("HLS" or the "Company") , a pharmaceutical company focusing on central nervous system and cardiovascular markets, announces that Bill Wells, Executive Chair of the Board, has retired from the board and his executive duties at...



News published on 19 january 2022 at 12:49 and distributed by: